Title : Enhancement of tumor tropism of mPEGylated nanoparticles by anti-mPEG bispecific antibody for ovarian cancer therapy.

Pub. Date : 2021 Apr 7

PMID : 33828191






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Here, we developed a bispecific antibody (BsAb; mPEG x HER2) that can easily provide HER2+ tumor tropism to mPEGylated liposomal doxorubicin (PLD) and further increase the drug accumulation in cancer cells via receptor-mediated endocytosis, and improve the cytotoxicity and therapeutic efficacy of HER2+ ovarian tumors. Doxorubicin erb-b2 receptor tyrosine kinase 2 Homo sapiens
2 Here, we developed a bispecific antibody (BsAb; mPEG x HER2) that can easily provide HER2+ tumor tropism to mPEGylated liposomal doxorubicin (PLD) and further increase the drug accumulation in cancer cells via receptor-mediated endocytosis, and improve the cytotoxicity and therapeutic efficacy of HER2+ ovarian tumors. Doxorubicin erb-b2 receptor tyrosine kinase 2 Homo sapiens